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The innate immune system is the first line of 
defense  against  pathogenic  microbes.  Phago-
cytic cells of the innate immune system, includ-
ing macrophages, DCs, and neutrophils, patrol 
host tissues and rapidly engulf any bacteria or 
particulate  microbes  they  encounter.  Once 
engulfed, most organisms are killed. However, 
several pathogens, like Listeria monocytogenes and 
Mycobacterium tuberculosis, have evolved strate-
gies  to  replicate  within  resting  macrophages 
and DCs (Pieters, 2008; Flannagan et al., 2009; 
Ray et al., 2009).
L. monocytogenes produces a hemolysin, liste-
riolysin O (LLO), which permits the bacterium 
to rupture phagosomes and escape into the cyto-
sol of infected cells. Consequently, strains lack-
ing expression of LLO (Hly) are avirulent. In 
addition, Hly L. monocytogenes fail to elicit the 
production of IFN- by infected macrophages 
(O’Riordan et al., 2002). Production of IFN-
 during L. monocytogenes infection is thought 
to be dependent on the detection of microbial 
products by a receptor present in the host cell 
cytosol (Leber et al., 2008). Although IFN- 
elicits an antiviral state that promotes resis-
tance to viral pathogens, IFN- production 
increases  the  survival  and  replication  of  L. 
monocytogenes, M. tuberculosis, and several other 
pathogenic bacteria (Auerbuch et al., 2004; 
Carrero et al., 2004; O’Connell et al., 2004; 
Stanley et al., 2007; Qiu et al., 2008; Martin 
et al., 2009; Shahangian et al., 2009). Mecha-
nisms for such probacterial effects of IFN- 
have not been clearly defined, although previ-
ous work has correlated IFN- production 
with increased cell death and differences in 
macrophage production of IL-10, IL-12, and 
TNF (Auerbuch et al., 2004; Carrero et al., 
2004, 2006; O’Connell et al., 2004).
In contrast to IFN-, IFN- is essential 
for host resistance to L. monocytogenes and other 
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Production of type I interferon (IFN; IFN-) increases host susceptibility to Listeria 
monocytogenes, whereas type II IFN (IFN-) activates macrophages to resist infection. We 
show that these opposing immunological effects of IFN- and IFN- occur because of 
cross talk between the respective signaling pathways. We found that cultured macrophages 
infected with L. monocytogenes were refractory to IFN- treatment as a result of down-
regulation of the IFN- receptor (IFNGR). The soluble factor responsible for these effects 
was identified as host IFN-. Accordingly, macrophages and dendritic cells (DCs) showed 
reduced IFNGR1 expression and reduced responsiveness to IFN- during systemic infection 
of IFN-–responsive mice. Furthermore, the increased resistance of mice lacking the IFN-
 receptor (IFNAR/) to L. monocytogenes correlated with increased expression of IFN-
–dependent activation markers by macrophages and DCs and was reversed by depletion of 
IFN-. Thus, IFN- produced in response to bacterial infection and other stimuli antago-
nizes the host response to IFN- by down-regulating the IFNGR. Such cross talk permits 
prioritization of IFN-–type immune responses and may contribute to the beneficial 
effects of IFN- in treatment of inflammatory diseases such as multiple sclerosis.
© 2010 Rayamajhi et al.  This article is distributed under the terms of an At-
tribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.jem.org/misc/terms.shtml).   
After six months it is available under a Creative Commons License (Attribution–
Noncommercial–Share Alike 3.0 Unported license, as described at http://
creativecommons.org/licenses/by-nc-sa/3.0/).
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with  IFN-.  However,  nearly  95%  of  this  IFN-–induced 
MHCII increase was blocked in BMM cultures that had been 
infected with wt Lm. These data suggest that the infection 
either specifically impaired expression of cell surface MHCII 
expression or more generally impaired macrophage responsive-
ness to IFN-.
Induction of MHCII transcription by IFN- requires the 
class II transactivator CIITA (Reith et al., 2005). To inves-
tigate  the  impact  of  wt  Lm  infection  on  IFN-–induced 
CIITA expression, we evaluated transcription of the CIITA-
pIV isoform in control and infected BMM. IFN- treat-
ment increased transcription of CIITA-pIV in mock-infected 
BMM as judged by semiquantitative RT-PCR (Fig. 1 B). 
However, no induction of CIITA-pIV transcripts was seen in 
IFN-–treated BMM previously infected with wt Lm. Simi-
larly, wt Lm infection prevented IFN-–induced luciferase 
reporter activity in RAW-CIITApIV reporter macrophages 
(Fig. 1 C), which were derived from RAW264.7 macro-
phages by stable transfection with a CIITA-pIV-luciferase 
reporter construct (Fortune et al., 2004). Thus, infection of 
macrophages with L. monocytogenes suppressed induction of 
both CIITA and cell surface MHCII.
To further discern whether the suppressive effects of L. 
monocytogenes were specific to CIITA, we developed an addi-
tional set of reporter cell lines. RAW264.7 cells were stably 
transfected with pHTS-GAS, a reporter construct contain-
ing four GAS elements upstream of a luciferase open reading 
frame. Reporter activity in the resulting RAW-GAS reporter 
cells was strongly induced by IFN- (Fig. 1 D) and inhibited 
by pretreatment with the STAT1-inhibitory anticancer agent 
fludarabine (not depicted; Frank et al., 1999). When RAW-
GAS.6 or additional independently derived GAS reporter cell 
lines were infected with wt Lm before IFN- treatment, the 
induction of reporter gene activity was reduced by 50% 
(Fig. 1 D). Infection with wt Lm failed to suppress luciferase 
reporter activity driven by an nfkb promoter (unpublished 
data). In contrast to wt Lm, infection with a live mutant L. 
monocytogenes strain lacking expression of the LLO hemoly-
sin (Hly Lm) had no impact on IFN-–dependent reporter 
gene activity (Fig. 1 D). Likewise, heat-killed wt Lm failed to 
significantly suppress RAW-GAS or RAW-CIITApIV cell 
reporter activity in response to IFN- (unpublished data). 
Finally, we evaluated levels of phospho (Y701) STAT1 after 
treatment of mock- or wt Lm–infected macrophages with 
recombinant IFN- (Fig. 1 E). The results indicated that 
IFN- treatment elicits significantly less pSTAT1 in macro-
phages infected for 6 h. Conversely, the response to IFN- 
was comparable to that of mock-infected cells at 2 hpi. Thus, 
prolonged infection of macrophages with viable L. monocyto­
genes that is capable of accessing the macrophage cytosol 
results in impaired responsiveness of these cells to IFN-.
Down-regulation of IFNGR expression accounts  
for the suppression of macrophage responsiveness to IFN-
To investigate the mechanism by which L. monocytogenes sup-
pressed IFN- responsiveness, we evaluated the impact of 
intracellular  pathogens  (Buchmeier  and  Schreiber,  1985;   
Dalton et al., 1993). IFN- drives the differentiation of resting 
macrophages into an activated antimicrobial state (M1) that 
more efficiently restricts the growth of intracellular pathogens 
(Gordon, 2003). The effects of IFN- require its binding to 
the IFN- receptor (IFNGR) 1 subunit of a heterodimeric 
cell surface IFNGR. This binding triggers receptor clustering 
and activates a Janus kinase (JAK)–signal transducer and activa-
tor of transcription (STAT) signaling pathway that culminates 
in the binding of STAT1 to IFN-–activated sequence (GAS) 
elements in the DNA adjacent to IFN-–stimulated genes 
(Platanias, 2005). The expression of several IFN-–stimulated 
genes is up-regulated by IFN-, including those coding for 
class II MHC proteins (MHCII) and the transcriptional acti-
vator of MHCII, CIITA (Reith et al., 2005).
IFN-  is  produced  in  abundance  by  L.  monocytogenes 
antigen-specific CD4+ and CD8+ T cells (Zenewicz and Shen, 
2007; Harty and Badovinac, 2008). However, within the first 
few days of infection, the major sources of IFN- are NK 
cells of the innate immune system (Humann et al., 2007; 
Kang et al., 2008). This innate wave of IFN- production 
peaks  around  24  h  post  infection  (hpi)  but  fails  to  limit   
L. monocytogenes growth, which continues for the first 72 h after   
systemic infection. The continued bacterial growth in the face 
of innate IFN- suggests that the early production of IFN- 
is not sufficient to activate macrophage bactericidal activity.
In  this  paper,  we  present  data  indicating  a  mechanism 
by  which  L.  monocytogenes  prevents  macrophage  activation 
by innate IFN-. We find that both infected and bystander 
macrophages  become  refractory  to  stimulation  by  IFN- 
early  after  L.  monocytogenes  infection.  This  refractory  state 
is  the  result  of  down-regulation  of  the  IFNGR,  which  is 
induced by IFN- released from L. monocytogenes–infected 
cells. IFN- down-regulates cell surface IFNGR and atten-
uates macrophage activation during systemic L. monocytogenes 
infection only in mice expressing the receptor for type I IFN, 
IFN- receptor (IFNAR). Mice lacking IFNAR expression 
consequently have increased expression of IFNGR and their 
reduced susceptibility to L. monocytogenes infection is depen-
dent on IFN-. These studies reveal a mechanism by which 
IFN- contributes to increased host susceptibility to bacterial 
infection and demonstrate a previously unappreciated mecha-
nism of antagonistic cross talk between type I and II IFNs.
RESULTS AND DISCUSSION
L. monocytogenes infection inhibits macrophage 
responsiveness to IFN-
To  test  whether  L.  monocytogenes  infection  might  suppress 
macrophage responses to IFN-, mouse BM-derived macro-
phages (BMMs) were subjected to a low multiplicity (mul-
tiplicity of infection [MOI] = 1) of WT L. monocytogenes (wt 
Lm) 2 h before treatment with IFN-. 20 h later, the infected 
and control BMMs were harvested and cell surface MHCII 
expression on live-gated cells was analyzed by flow cytometry 
(Fig. 1 A). Mock-infected BMM treated with IFN- showed 
50–100× higher MHCII staining than BMM not treated   JEM VOL. 207, February 15, 2010  329
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expression of genes involved in responses to IFN-. In partic-
ular, the suppressed transcription of ifngr1 might be expected 
to interfere with cell surface IFNGR expression and, thus, 
macrophage responsiveness to IFN-.
We thus evaluated cell surface staining for IFNGR1 and 
IFNGR2 subunits. IFNGR1 detection was highly specific 
using a two-step staining procedure (Fig. S1). Our results indi-
cated that surface expression of IFNGR1 was rapidly reduced 
in the wt Lm–infected cells, with a maximal reduction of 
wt Lm infection on expression of several macrophage genes 
important for responsiveness to IFN-. Total RNA was har-
vested from mock- and wt Lm–infected BMM and used for 
Affymetrix genechip analysis. The normalized expression of 
stat1 and jak2 increased by nearly 10-fold with wt Lm infec-
tion, whereas jak1 and ifngr2 expression were not affected 
(Fig. 2 A). In contrast, expression of ifngr1 was reduced by 
nearly sevenfold in the wt Lm–infected macrophages. These 
data indicate that wt Lm infection dramatically affects the 
Figure 1.  L. monocytogenes infection suppresses macrophage responses to IFN-. (A) Cell surface MHC class II (MHCII) expression on live-gated 
C57BL/6 BMM treated with IFN- after mock infection (light shading) or infection with wt Lm (dark shading) at MOI = 1. The clear histogram depicts 
MHCII expression on mock-infected cells not treated with IFN-. (B) Semiquantitative RT-PCR was performed using complementary DNA template pre-
pared from mock- or wt Lm–infected BMM at 10 hpi. Treatment with IFN- occurred 2 h after infection. (C) RAW264.7-CIITApIV reporter cells (Fortune  
et al., 2004) were mock or wt Lm infected. At 2 hpi, cells received fresh media containing 0 (none) or 100 U/ml IFN-. Luciferase reporter activity was 
measured 6 h later. (D) RAW264.7 cells were transfected with a GAS-luciferase reporter construct. A stable IFN-–responsive transfectant (RAW-GAS.6) was 
treated with IFN- at 2 hpi with wt Lm or a hemolysin-deficient L. monocytogenes strain (Hly Lm). Infected and control RAW-GAS.6 cells were lysed to 
assay luciferase activity at 10 hpi. (E) Immunoblotting for phospho-STAT1 after IFN- treatment of mock-infected or wt Lm–infected cells. Cells were 
treated with IFN- at the indicated times after infection and lysed 5, 15, or 30 min later. Similar results were seen using lysates prepared from four inde-
pendent experiments. For C and D, bars show SE from three independent samples. Horizontal lines represent the level of expression on uninfected cells. 
Error bars indicate SEM. A Student’s t test was used to calculate p-values where indicated. Experiments in A–D were repeated at least three times.330 L. monocytogenes exploits IFNGR down regulation | Rayamajhi et al.
The relative abundance of ifngr1 and ifngr2 transcripts 
was  also  evaluated  in  the  mock-  and  wt  Lm–infected 
BMM using quantitative RT-PCR. As predicted from the 
Affymetrix  analysis,  ifngr1  transcription  was  significantly 
reduced within 4 hpi (Fig. 2 D). However, we failed to 
observe significant reductions in ifngr2 transcription at any 
time point after the wt Lm infection. Given the contrasting 
behaviors of ifngr2 transcripts and IFNGR2 surface staining, 
we hypothesize that the stability or cell surface localization 
of IFNGR2 is tightly linked to that of IFNGR1 at a post-
transcriptional level. Indeed, BMM from B6.IFNGR1/ 
mice failed to down-regulate IFNGR2 when infected with 
wt Lm (Fig. 2 E).
Together, these findings demonstrated that wt Lm infec-
tion triggers a rapid decrease in cell surface expression of 
both IFNGR1 and IFNGR2 subunits of the IFNGR, albeit 
through distinct mechanisms. The reduced availability of the   
60% at 8 hpi (Fig. 2 B). The reduction in IFNGR1 sur-
face staining paralleled a reduction in total IFNGR1 protein 
levels, as determined by intracellular staining for IFNGR1 
in saponin-permeabilized mock- and wt Lm–infected BMM 
(Fig. 2 C). Detection of IFNGR2 required a three-step stain-
ing procedure. Cell surface staining for IFNGR2 was also 
reduced  by  wt  Lm  infection  with  an  extent  and  kinetics 
similar to that of IFNGR1 (Fig. 2 B). In contrast, cell sur-
face staining for the integrin CD11b was not affected by wt 
Lm infection (Fig. 2 B; and Fig. S2, raw mean fluorescence 
intensity [MFI]). Thus, down-regulation of the IFNGR sub-
units is a specific consequence of infection. BMMs fail to 
produce IFN- in response to wt Lm (unpublished data), 
and IFN-/ BMM retained the ability to down-regulate 
IFNGR in response to wt Lm infection (unpublished data). 
Thus, the specific loss of cell surface IFNGR expression was 
not attributable to ligand-induced IFNGR internalization.
Figure 2.  Suppression of macrophage responsiveness to IFN- after L. monocytogenes infection reflects rapid down-regulation of the  
IFNGR. (A) Total RNA was isolated from mock- and wt Lm–infected BMM at 10 hpi and hybridized to Affymetrix genechips. The mean fold change in 
normalized expression between mock- and wt Lm–infected BMM is shown for the indicated genes encoding proteins involved in IFN- signaling.  
(B) Mock-infected and wt Lm–infected BMMs were harvested at the indicated hpi, stained with antibodies to IFNGR1, IFNGR2, or CD11b, and analyzed by 
flow cytometry. Mean channel fluorescence intensities (MFI) from three infected samples per group were determined and normalized to the mean MFI of 
three mock-infected samples using the following formula: relative surface staining = (MFI Lm infected)/(MFI mock infected). (C) C57BL/6 BMMs were 
mock or wt Lm infected. One half of each sample was stained for cell surface IFNGR1 and the other half was permeabilized with saponin and stained for 
total cellular IFNGR1. Shown are representative histograms of IFNGR1 staining for each BMM population. MFIs are indicated in parentheses. (D) Real-time 
RT-PCR was used to quantify the relative transcript abundance of IFNGR1 and IFNGR2 at the indicated hpi. Samples were from the experiment in B.  
(E) B6.IFNGR1/ BMMs were mock or wt Lm infected and analyzed for surface expression of IFNGR2 and CD11b. Shown is relative surface staining on wt 
Lm–infected cells. Error bars indicate SEM for three samples per condition. Asterisks indicate significant (P < 0.05) variations between Lm-infected and 
mock-infected samples. ns indicates P > 0.05. Horizontal lines represent the level of expression on uninfected cells. Experiments in B–E were repeated at 
least three times.JEM VOL. 207, February 15, 2010  331
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L. monocytogenes. Furthermore, the results showed that IFNGR1   
was down-regulated on nearly all APCs in L. monocytogenes–
infected mice (Fig. 3 A), despite the fact that only a frac-
tion of APCs are infected with live bacteria at the infection 
dose used (104). We thus hypothesized that a soluble factor 
released from L. monocytogenes-infected cells was responsible 
for IFNGR1 down-regulation.
A soluble factor released from infected cells mediates 
IFNGR down-regulation and suppressed responses to IFN-
As a first step to directly evaluate whether a soluble factor 
mediated IFNGR down-regulation, BMMs were infected at 
a low multiplicity (MOI = 5) with a wt Lm strain express-
ing enhanced GFP. Both infected (GFPhi) and uninfected 
(GFPlo) BMM in these cultures down-regulated IFNGR1 
expression (Fig. 3 B). In contrast, BMM infected with Hly 
Lm that expressed enhanced GFP failed to down-regulate 
IFNGR  provides  a  mechanistic  basis  for  the  reduction  in 
responsiveness of wt Lm–infected BMM to IFN-.
IFNGR is selectively down-regulated on antigen presenting 
cell populations
When C57BL/6 mice were infected i.v. with a sublethal 
dose of wt Lm (10,000 cfu), both splenic myeloid (CD11b+) 
and B lymphocyte (B220+CD19+) populations showed sig-
nificant reductions in IFNGR1 staining from 24 to at least   
48 hpi (Fig. 3 A). IFNGR1 staining remained low on CD11c+ 
gated DCs for at least 79 hpi (Fig. 3 A and see Fig. 5 A). 
Cell surface IFNGR1 staining was also slightly, but not sig-
nificantly, reduced on NK1.1+CD3 NK cells (P > 0.05). 
However,  no  reduction  was  seen  in  IFNGR1  staining   
on gated CD3+ T cells. These results indicated that down-
regulation of IFNGR1 selectively occurs on APC populations 
during the early stages of systemic infection with virulent   
Figure 3.  IFNGR down-regulation is restricted to APC populations and is a result of a suppressive soluble factor. (A) C57BL/6 mice (n = 3) were 
infected i.v. with 104 cfu wt Lm or given PBS alone. Spleens were harvested at indicated hpi and single cell suspensions were stained for IFNGR1 expres-
sion on the indicated cell populations by flow cytometry. Shown are mean + SEM IFNGR1 staining intensities from infected mice normalized to the same 
populations from mock-infected mice. Horizontal line represents the level of expression on uninfected cells. (B) BMMs were infected with GFP-tagged WT 
or ∆Hly Lm stains at MOI = 5. At 5 hpi, cells were lifted and stained to evaluate surface IFNGR1 expression on the infected (GFPhi) and uninfected (GFPlo) 
populations. The bottom panel is a graphical depiction of the mean + SEM of normalized IFNGR1 expression levels for the GFPhi and GFPlo BMM popula-
tions. (C) Supernatants were harvested from WT or ∆Hly infected donor BMMs at 8 hpi, filter sterilized, and transferred onto naive recipient BMMs. At 8 h 
after transfer, surface IFNGR1 expression was evaluated on the recipient BMMs by flow cytometry. Mean + SEM surface expression relative to mock-
infected control samples is depicted. (D) RAW-CIITApIV reporter macrophage cells were treated for 6 h with sterile filtered supernatants from mock- or  
wt Lm–infected BMM, both of which were spiked with 100 U/ml IFN-. Supernatants were prepared as in C and luciferase activity was determined as in 
Fig. 1. Experiments were repeated at least three times. Error bars indicate SEM. *, P < 0.05.332 L. monocytogenes exploits IFNGR down regulation | Rayamajhi et al.
with TLR agonists or infected with wt Lm as a control. 
Similar IFNGR1 down-regulation was seen in both B6 and 
B6.MyD88/ BMMs that were infected with wt Lm, indi-
cating that MyD88-dependent TLR signaling was dispens-
able for induction of the soluble IFNGR down-regulating 
factor by live cytosolic L. monocytogenes (Fig. 4 A). Nonethe-
less, treatments with specific TLR agonists (including non-
methylated CpG oligodeoxynucleotides [ODNs], poly I:C, 
and, to a lesser extent, LPS) did induce significant IFNGR1 
down-regulation (Fig. 4 A). In some cases, these treatments 
required MyD88 expression by the BMM. Scrambled con-
trol ODNs and the triacyl-lipopeptide Pam3Cys failed to 
elicit down-regulation of IFNGR1.
Type I IFNs are produced by macrophages in response to 
cytosolic (but not Hly) L. monocytogenes infection, as well 
as by stimulation with CpG ODN, LPS, and pIC. To deter-
mine whether IFN- might be the host factor responsible 
for IFNGR down-regulation, we evaluated IFNGR1 surface 
expression on macrophages from IFNAR1/ mice after wt Lm 
infection. Strikingly, the infected IFNAR/ macrophages 
failed to significantly down-regulate IFNGR1 or IFNGR2 
(Fig. 4 B). We also used reciprocal transfers of sterile filtered 
supernatants from infected C57BL/6 or IFNAR1/ donor 
IFNGR1 in either GFP+ or GFP BMM. We next evaluated 
the ability of sterile filtered conditioned media from mock- 
or wt Lm–infected donor BMM to induce IFNGR down-
regulation on uninfected recipient BMM. 8 h after transfer of 
the respective conditioned media, cell surface IFNGR1 was 
evaluated on recipient BMM. Recipient BMM treated with 
media from mock-infected donor BMM failed to down-
regulate IFNGR1 (Fig. 3 C). In contrast, conditioned media 
from wt Lm–infected BMM induced a decrease in IFNGR1 
staining that was similar to that seen with direct infection 
of the BMM by wt Lm. In addition, a soluble factor was 
sufficient to significantly suppress IFN-–dependent reporter 
gene activity in RAW-CIITApIV reporter cells, as shown 
by transfer of conditioned media from wt Lm– or mock-
infected BMM (Fig. 3 D). Together, these results confirmed 
that a factor secreted from wt Lm–infected macrophages was 
sufficient to induce both IFNGR down-regulation and sup-
pression of macrophage gene induction by IFN-.
IFN- is responsible for IFNGR down-modulation
We asked whether other inflammatory stimuli might also 
induce macrophages to secrete factors that down-regulate the 
IFNGR. C57BL/6 and MyD88/ BMMs were thus treated 
Figure 4.  Type I IFN mediates IFNGR down-regulation. (A) C57BL/6 (black) or MyD88/ (gray) BMMs were infected with wt Lm at MOI = 5 or 
treated with the indicated TLR agonists as described in Materials and methods. After 8 h of infection or treatment, BMMs were lifted and surface IFNGR1 
expression was assessed by flow cytometry. Shown is mean + SEM staining for IFNGR1 on each set of BMM relative to untreated BMM of the same geno-
type. (B) C57BL/6 or B6.IFNAR1/ BMMs were infected with wt Lm at MOI = 5. At 8 hpi, surface expression of IFNGR1 and IFNGR2 was quantified by 
flow cytometry. Shown is the mean + SEM relative surface staining of each IFNGR subunit normalized to staining of mock-infected BMM. (C) Sterile fil-
tered supernatants from mock- or wt Lm–infected donor BMM of the indicated genotype were transferred to BMM of the indicated recipient genotype as 
in Fig. 3. Shown is the relative surface expression of IFNGR1 in each cell population. (D) C57BL/6 BMMs were infected with wt Lm or in parallel treated 
with the indicated recombinant murine cytokines as described in Materials and methods. Wt Lm and IFN- induced equivalent IFNGR1 down-regulation. 
Experiments were repeated at least three times. Horizontal lines represent the level of expression on uninfected cells. Error bars indicate SEM. *, P < 0.05.JEM VOL. 207, February 15, 2010  333
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terial infections. Indeed, IFNGR1 and MHCII cell surface 
staining were dramatically reduced on CD11c+CD3 DCs 
from  wt  Lm–infected  B6  mice  when  compared  with  the 
same population from infected IFNAR1/ or uninfected 
C57BL/6 mice (Fig. 5 A). Similar results were seen on gated 
Ly6GCD11b+ inflammatory monocytes (unpublished data). 
It was previously reported that infection with wt Lm elicits 
similar serum concentrations of IFN- in IFNAR/ and 
IFNAR+/+ mice (Auerbuch et al., 2004). Thus, the respec-
tive increases in MHCII expression seen in infected B6 and 
B6.IFNAR1/ mice are not explained by differences in the 
amounts of IFN- produced in each mouse strain.
We further demonstrated that the differences in MHCII 
expression were the result of IFN-, rather than other factors, 
by evaluating staining on cells from B6 and B6.IFNAR1/ 
mice  given  a  neutralizing  antibody  to  IFN-  (XMG1.2) 
before wt Lm infection. The XMG1.2 treatment reduced 
MHCII expression on gated APCs to a similar basal level 
in both mouse strains (Fig. 5 A). Thus, although MHCII 
expression  was  increased  by  the  infection  in  APCs  from 
both IFNAR-expressing and IFNAR1-deficient mice, the 
response was more pronounced in the IFNAR1/ animals.
Bacterial burdens present in the livers of infected B6, 
B6.IFNAR1/, and IFN-–depleted B6.IFNAR1/ mice 
were also determined at 79 hpi with wt Lm. Organs from 
the control B6.IFNAR1/ mice harbored 3–4 logs fewer 
bacteria when compared with C57BL/6 mice (Fig. 5 B), 
confirming the heightened resistance of IFNAR1/ mice 
to  wt  Lm  infection.  However,  this  heightened  resistance 
was completely abrogated by antibody-mediated depletion 
of IFN- in the B6.IFNAR1/ mice pretreated with 500 µg 
BMMs to induce IFNGR down-regulation on uninfected 
recipient C57BL/6 or IFNAR1/ BMMs. Staining for cell 
surface IFNGR1 on recipient BMM revealed that only those 
macrophages expressing the IFNAR were capable of signifi-
cantly down-regulating IFNGR1 (Fig. 4 C). Thus, IFNAR 
signaling was necessary for the response to, but not the induc-
tion of, the factors that down-regulate the IFNGR.
To determine whether type I IFN was sufficient to medi-
ate IFNGR down-regulation, we treated C57BL/6 BMM 
with a panel of recombinant commercial mouse cytokines. 
Down-regulation of IFNGR1 was not seen in macrophages 
treated with IL-6 or IL-10 (Fig. 4 D), two cytokines which 
are known to suppress IFN- signaling (Nagabhushanam 
et al., 2003; Dikopoulos et al., 2005; Carrero et al., 2006; 
Murray, 2007). In addition, IFNGR down-regulation was 
not seen in cells treated with recombinant IL-28/IFN-, 
a cytokine which shares signaling components with IL-10 
and IFN- (Donnelly et al., 2004). However, recombi-
nant IFN- induced a similar degree of IFNGR1 down-
regulation as seen during wt Lm infection (Fig. 4 D). As 
expected, IFNGR1 down-regulation was not induced by 
IFN- treatment of IFNAR1/ BMM (unpublished data). 
These data indicate that IFNAR signaling is necessary and 
sufficient for down-regulation of IFNGR1.
Increased resistance of IFNAR1/ mice to L. 
monocytogenes infection correlates with increased 
macrophage activation and requires IFN-
The  results  in  the  previous  sections  suggested  that  APC 
populations  from  IFNAR1/  mice  might  respond  bet-
ter to IFN- and, thus, more efficiently clear in vivo bac-
Figure 5.  The resistance of IFNAR/ APCs to IFNGR down-regulation correlates with their increased activation by IFN- and increased 
IFN-–dependent resistance of IFNAR/ mice to systemic L. monocytogenes infection. (A) B6.IFNAR1/ and congenic C57BL/6 mice were 
treated with PBS or 500 µg of anti–IFN- (XMG1.2) diluted in PBS 17 h before infection with a sublethal dose of wt Lm (9,000 cfu). Spleens and livers 
were harvested 72 h later. Gated monocytes and DCs were analyzed for cell surface MHCII expression. The MFI for each histogram is indicated in paren-
theses. Data are representative of results from three to four mice per group. (B) Livers from the infected mice were homogenized and dilution plated to 
determine bacterial burdens. Each point indicates an individual mouse. Bars indicate the mean values. The asterisk indicates a p-value of <0.05. Experi-
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O’Connell et al., 2004). L. monocytogenes–infected IFNAR/  
mice also produce lower amounts of IL-10 (perhaps because 
of increased splenocyte apoptosis) and increased production 
of IL-12 and TNF when compared with control animals 
(Auerbuch et al., 2004; Carrero et al., 2006). We propose 
that  there  may  be  a  common  mechanistic  basis  for  such 
increased resistance. Given our data and previous results that 
IFN- enhances TNF production and suppresses IL-10 pro-
duction by macrophages (Chomarat et al., 1993; Bundschuh 
et al., 1997; Déry and Bissonnette, 1999), we propose that 
the increased resistance of IFNAR/ to L. monocytogenes is 
a result of their failure to down-regulate the IFNGR. Con-
sistent with this model, we show that APCs are more highly 
activated after infection of IFNAR/ mice and that these 
mice more efficiently limit bacterial replication at early times 
after infection. Indeed, both this increased APC activation 
and increased resistance to infection are completely abrogated 
by depletion of IFN-. A potential alternative explanation 
of our findings is that the increased IL-10 in the WT, but 
not IFNAR1/, mice suppresses the production of IFN-. 
Indeed, IL-10 suppresses IFN- production induced by treat-
ment of cultured splenocytes from SCID mice with killed   
L. monocytogenes (Tripp et al., 1993). However, it was pre-
viously shown, and our findings confirm, that sera of both 
control and IFNAR/ mice infected with live L. monocyto­
genes contain similar amounts of IFN- (Auerbuch et al., 
2004).  Thus,  we  favor  the  interpretation  that  IFN- 
production in WT mice impairs responsiveness of APCs to 
IFN- and, thus, the host’s ability to limit bacterial repli-
cation and dissemination.
Recently, IFNAR/ mice have also been shown to resist 
infection with several additional pathogenic bacteria (Stanley 
et al., 2007; Qiu et al., 2008; Martin et al., 2009; Shahangian 
et al., 2009). Some of these bacteria, such as M. tuberculosis  
and Chlamydia trachomatis, are known to suppress cellular 
responses to IFN- (Belland et al., 2003; Kincaid and Ernst, 
2003; Pai et al., 2003). It thus appears likely that the mecha-
nism for antagonistic cross talk between IFN- and IFN- 
that we describe in this paper also impacts susceptibility to 
these  other  pathogenic  bacteria.  Additional  understanding 
of the mechanisms regulating IFNGR down-regulation by 
IFN- may lead to improved treatments for a variety of 
infectious and inflammatory diseases.
MATERIALS AND METHODS
Mice. IFNAR/, IL-6/, IFNGR/, and IFN-/ mice were crossed 
to C57BL/6J (The Jackson Laboratory) for >10 generations. B6.IFNAR1/ 
mice were originally obtained from DA. Portnoy (University of California, 
Berkeley, Berkeley, CA). STAT1/ and isogenic 129/Sv mice were ob-
tained from Taconic. Mice were housed in the National Jewish Health Bio-
logical Resource Center. All studies were approved by the National Jewish 
Health Institutional Animal Care and Use Committee.
Mouse infections. Female mice between 8 and 10 wk of age were used for 
all in vivo experiments. Mice were infected (tail vein) with 0.5–2 × 104 cfu of 
log-phase mouse passaged L. monocytogenes strain 10403S. 24–96 h later, spleens 
and livers were harvested for analysis. Spleens were treated with 0.3% collage-
nase type IV (Worthington Biochemical Corporation) to release phagocytic 
neutralizing anti–IFN- antibody (XMG1.2). Indeed, the 
bacterial burdens in the IFN-–depleted IFNAR1/ mice 
were not significantly different from those seen in control 
or IFN-–depleted C57BL/6 mice. Thus, the heightened 
responsiveness of IFNAR1/ mice to IFN- accounts for 
their increased resistance to L. monocytogenes infection.
Concluding remarks
Our studies reveal that production of IFN- early after L. 
monocytogenes infection down-regulates ifngr1 transcription and, 
hence, reduces surface expression of the IFNGR by 50–60%. 
Despite the partial nature of this reduction in IFNGR expres-
sion, the induction of IFN-–dependent gene expression by 
APCs is clearly affected both in vitro and in vivo. As shown in 
this paper, cells infected with L. monocytogenes respond poorly 
to IFN-, and supernatant from these cells impairs transcrip-
tional  and  translational  up-regulation  of  IFN-–inducible 
genes. To our knowledge, the ability of IFN- to down-
regulate IFNGR expression by APCs has not been previously 
reported. However, our findings do provide an explanation for 
the previously described ability of IFN- to interfere with 
binding of IFN- to macrophages and B cells (Thompson 
et al., 1985; Yoshida et al., 1988). Our findings are also consis-
tent with several older studies that showed that IFN- treat-
ment antagonizes the response of mouse and mature human 
macrophages to treatment with IFN- (Ling et al., 1985; Inaba 
et al., 1986; Yoshida et al., 1988).
We  speculate  that  the  ability  of  IFN-  to  suppress 
IFNGR expression has evolved to permit the integration of 
coincident signals that occur during infection with agents that 
induce concurrent expression of both IFN- and IFN-. 
By suppressing responsiveness of APCs to IFN-, IFN- 
may prioritize the development of an antiviral IFN-–type 
response to more effectively limit viral infections. The ability 
of IFN- to suppress IFN-–type responses may also benefit 
the host by limiting collateral damage that might otherwise 
result from the rapid activation of macrophages and other 
APCs by IFN-. Indeed, IFN- is commonly used to treat 
relapsing-remitting multiple sclerosis, an inflammatory auto-
immune disease of the central nervous system (Hemmer et al., 
2006; Borden et al., 2007). Likewise, IFN- reduces disease 
severity in the murine multiple sclerosis model of experimental 
autoimmune encephalitis. Recent work shows the protective 
effect of IFN- in experimental autoimmune encephalitis 
requires IFNAR1 expression on mouse myeloid cells (Prinz 
et al., 2008). In light of our findings, one may speculate that 
a key effect of IFN- is to down-regulate IFNGR expres-
sion on myeloid cells, thereby reducing stimulation of auto-
immune T cells and the consequences of IFN- produced by 
such T cells. Given that IFN- does not reduce IFNGR 
expression in T cells, the integration of IFN- and IFN- 
signals in T cells must entail distinct mechanisms.
IFNAR/ mice have been shown to have heightened 
resistance to systemic L. monocytogenes infection, as judged 
by reduced bacterial burdens beginning within 3 or 4 d of 
systemic infection (Auerbuch et al., 2004; Carrero et al., 2004; JEM VOL. 207, February 15, 2010  335
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Pacific Blue (N418; eBioscience). Stained cells were run on FACSCalibur 
(BD)  or  DakoCytomation  CyAn  (Dako)  machines  and  analyzed  using 
FlowJo software (Tree Star, Inc.).
Affymetrix analysis and RT-PCR.  Total RNA was isolated from C57BL/6 
BMM 10 h after mock or wt Lm infection using the RNeasy kit with DNase 
treatment  (QIAGEN).  For  each  of  two  to  three  independent  infections, 
RNA was pooled from 3–6 wells of BMM and hybridized to Affymetrix 
GeneChip Mouse Genome 430 2.0 Arrays by the University of Colorado 
Cancer Center Gene Expression core. Intensity data from chips was normal-
ized and probe sets given a p (present)-value by Genechip operating software 
were further analyzed. Raw microarray data are available from the National 
Center for Biotechnology Information Gene Expression Omnibus, Acces-
sion no. GSE19374. To identify differentially expressed genes (P < 0.05 by 
ANOVA), normalized hybridization data were further analyzed using Gene-
Sifter software (Geospiza). For RT-PCR, complementary DNA synthesis was 
conducted with 1 µg of total RNA using Oligo(dT) primers (Promega). 
Semiquantitative RT-PCR was done as previously described (Humann et al., 
2007) using oligonucleotide primers 5-GAGACTGCATGCAGGCAGCA-
3 and 5-GGTCGGCATCACTGTTAAGGA-3 for C2ta­pIV. Real-time 
quantitative PCR was performed using SYBR Green PCR Master Mix (Ap-
plied Biosystems) and an ABI PRISM 7700 Sequence detector. Conditions 
for amplification of the target sequences were the following: 2 min at 50°C, 
10 min at 95°C, and then 40 cycles of 15 s at 95°C and 1 min at 60°C. Effi-
ciency of amplification with each primer set was confirmed in control ex-
periments. All samples were run in triplicate. Commercial oligonucleotide 
primer sets from Applied Biosystems were used to quantify ifngr1 and ifngr2 
transcripts. The ifngr1 or ifngr2 transcript abundance in each sample was nor-
malized to gapdh. The fold change in expression was calculated using 2Ct 
method.
Supernatant transfers. Culture supernatants from mock- or L. monocyto­
genes–infected donor BMMs were harvested at 8 hpi and centrifuged at 500 g 
for 5 min. Supernatants were sterile filtered through a 0.2-µm syringe filter and 
frozen at 20°C. Donor BMMs were stained for IFNGR1 to confirm 
infection-induced down-regulation. Conditioned supernatants were thawed 
and 1 ml was used to replace media for 106 uninfected recipient BMM or 
RAW-CIITApIV  macrophages  in  12-well  plates.  Recipient  cells  were 
harvested for analysis of IFNGR surface expression at 8 h or luciferase activity 
at 6 h.
TLR and cytokine stimulations. Uninfected BMMs were treated with 
the indicated TLR agonists and cytokines for 8 h before analysis. CpG, 
scrambled CpG, and ultrapure LPS (InvivoGen) were used at 1 µM (CpG) 
and 10 ng/ml (LPS). Poly I:C (GE Healthcare) was used at 10 µg/ml. Pam-
3Cys was a gift from R. Kedl (Colorado University, Denver, CO) and used 
at 1 µg/ml. Recombinant mouse IL-6, IL-10, and IL-28 (eBioscience) were 
used at respective final concentrations of 0.01, 0.3, and 0.2 ng/ml. Recom-
binant mouse IFN- (R&D Systems) was used at 100 U/ml.
Statistical analysis. All experiments were repeated at least three times. As-
terisks (*) in the figures indicate differences deemed significant (P < 0.05) by 
a two-tailed Student’s t test or the Mann-Whitney test. All error bars in 
graphs indicate SEM for three samples per experimental group.
Online supplemental material. Fig. S1 illustrates control stains for 
IFNGR1 on WT and IFNGR1/ BMM, demonstrating the specificity 
of the staining procedures. Fig. S2 depicts the raw unmanipulated MFIs 
for  IFNGR1,  IFNGR2,  and  CD11b  staining  in  a  representative  ex-
periment.  Online  supplemental  material  is  available  at  http://www.jem 
.org/cgi/content/full/jem.20091746/DC1.
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and adherent cell populations then processed into single cell suspensions for 
staining and flow cytometry. Bacterial CFUs in infected tissues were deter-
mined by dilution plating as previously described (Humann et al., 2007).
Macrophages and cell lines. To culture BMM, cells were flushed from 
both femurs of mice and cultured for 6 d in BM macrophage media (DMEM 
supplemented with 10% FBS, 1% sodium pyruvate, 1% L-glutamine, 1% 
penicillin/streptomycin,  2-mercaptoethanol,  and  10%  L-cell  conditioned 
media). Fresh media was added at day 3 and BMMs were used for experi-
ments on day 7. RAW264.7 macrophage cells stably transfected with a 
CIITApIV-luciferase construct (RAW-CIITApIV reporter cells) were pro-
vided by J. Ernst (New York University, New York, NY; Fortune et al., 
2004). RAW.GAS6 reporter macrophages were generated in our laboratory 
by stable transfection with linearized pHTS-GAS (Biomyx Technology). 
RAW-CIITApIV and RAW-GAS.6 reporter cells were cultured with selec-
tion in 400 µg/ml neomycin or 100 µg/ml hygromycin, respectively.
Infection of cultured macrophages and immunoblotting. BMM or 
RAW reporter cell lines were cultured overnight in antibiotic-free media and 
then infected with log-phase L. monocytogenes 10403S (wt Lm) or the isogenic 
Hly strain provided by D.A. Portnoy. Macrophages were infected at MOI = 
1–5 for 30 min, washed three times in PBS, and given fresh media. At 1 h 
after infection, gentamicin was added to a concentration of 50 µg/ml to kill 
extracellular bacteria. For immunoblotting studies, control or infected macro-
phages were treated with 100 U/ml IFN- at 2 or 6 hpi. Cells were rinsed in 
PBS and lysed in SDS-PAGE buffer (62.5 mM Tris-HCL, pH 6.8, 2% SDS, 
10% glycerol, 50 mM DTT, and 0.01% bromophenol blue) supplemented 
with HALT phosphatase and protease inhibitors (Thermo Fisher Scientific). 
Lysates were separated by SDS-PAGE and immunoblotted with rabbit anti-
pY701 STAT1, total STAT1, or mouse anti-actin using commercial anti-
bodies (Cell Signaling Technology and Millipore) followed by secondary 
HRP-labeled anti–rabbit and anti–mouse (Thermo Fisher Scientific).
Luciferase assay. Reporter cells were plated at 2 × 106 per well in 6-well 
plates and mock-infected or infected with WT or Hly L. monocytogenes. At 
2 hpi, the culture media was replaced with fresh media containing 50 µg/ml 
gentamicin plus 0 or 100 U/ml of recombinant mouse IFN- (Invitrogen). 
Lysates were harvested at 10 hpi using lysis buffer from the Enhanced Lucifer-
ase Assay kit (BD) and frozen at 20°C. Luminescence was measured using 
injectors and kit reagents on a Synergy 2 reader with injectors (BioTek).
Flow cytometry. Collagenase-treated splenocytes were incubated 1 min in 
ACK lysis buffer to lyse red blood cells then pelleted (Humann et al., 2007). 
BMMs were lifted from culture dishes with Nozyme (Specialty Media) and 
pelleted. Fc receptors were blocked before staining using supernatant from 
hybridoma  2.4G2  (rat  anti-CD16/32).  Surface  staining  used  PBS/1% 
FCS/0.01% NaN3. Intracellular staining used Cytofix/Cytoperm solutions 
(BD). To detect MHCII and IFNGR1 expression, cells were stained with 
biotinylated antibodies to pan-MHCII (eBioscience; clone M5/114.15.2) or 
IFNGR1/CD119 (BD), followed by streptavidin-APC secondary antibody. 
Directly conjugated M5/114.15.2 (BioLegend) was used for some experi-
ments. To detect IFNGR2, we used a three-step staining procedure with 
hamster anti–mouse IFNGR2 (Abcam; antibody 21570), followed by bioti-
nylated goat anti–hamster IgG (eBioscience) and streptavidin-APC (eBiosci-
ence). To compare the effects of various treatments on receptor surface 
expression levels, the mean channel fluorescence intensities (MFIs) for each 
of three infected or treated samples per group were normalized to mean 
control MFI for the same receptor using the following formula: relative sur-
face staining = (MFI treated)/(mean MFI control). All graphs depict the 
mean of these calculations plus SE. For statistical analyses, we compared the 
raw MFIs for each of at least three control and three treated samples. The 
following antibodies were used to identify splenocyte populations: NK1.1-
PE (PK136), Ly6G-PE (1A8), CD8-PE (53–6.7), CD4-FITC (RM4-5), 
and B220-PECy5 (TÜ116; BD); and F480-PECy5 (BM8), CD11b-PECy5 
(M1/70), CD19-PE (MB19-1), CD3-PECy5 (4B12), and CD11c-PE or 336 L. monocytogenes exploits IFNGR down regulation | Rayamajhi et al.
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